BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3356449)

  • 1. Biochemical and genetic analysis of the OKa blood group antigen.
    Williams BP; Daniels GL; Pym B; Sheer D; Povey S; Okubo Y; Andrews PW; Goodfellow PN
    Immunogenetics; 1988; 27(5):322-9. PubMed ID: 3356449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Oka blood group antigen is a marker for the M6 leukocyte activation antigen, the human homolog of OX-47 antigen, basigin and neurothelin, an immunoglobulin superfamily molecule that is widely expressed in human cells and tissues.
    Spring FA; Holmes CH; Simpson KL; Mawby WJ; Mattes MJ; Okubo Y; Parsons SF
    Eur J Immunol; 1997 Apr; 27(4):891-7. PubMed ID: 9130641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oka: an erythrocytic antigen of high frequency.
    Morel PA; Hamilton HB
    Vox Sang; 1979; 36(3):182-5. PubMed ID: 462906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan.
    Badcock G; Pigott C; Goepel J; Andrews PW
    Cancer Res; 1999 Sep; 59(18):4715-9. PubMed ID: 10493530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of three novel monoclonal anti-OKa.
    Tian MH; Halverson GR
    Immunohematology; 2009; 25(4):174-8. PubMed ID: 20406026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A human cell-surface antigen defined by a monoclonal antibody and controlled by a gene on human chromosome 1.
    Andrews PW; Knowles BB; Parkar M; Pym B; Stanley K; Goodfellow PN
    Ann Hum Genet; 1985 Jan; 49(1):31-9. PubMed ID: 2416262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a cell-surface antigen produced by a gene on human chromosome 3 (cen-q22) and not expressed by Rhnull cells.
    Miller YE; Daniels GL; Jones C; Palmer DK
    Am J Hum Genet; 1987 Dec; 41(6):1061-70. PubMed ID: 3120581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a recombinant anti-Vel immunoglobulin M to identify Vel-negative donors.
    van der Rijst MVE; Lissenberg-Thunnissen SN; Ligthart PC; Visser R; Jongerius JM; Voorn L; Veldhuisen B; Vidarsson G; van den Akker E; van der Schoot CE
    Transfusion; 2019 Apr; 59(4):1359-1366. PubMed ID: 30702752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Tcb, an antibody that defines a red cell antigen antithetical to Tca.
    Lacey PA; Block UT; Laird-Fryer BJ; Moulds JJ; Bryant LR; Giandelone JA; Linnemeyer DR
    Transfusion; 1985; 25(4):373-6. PubMed ID: 4024236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.
    Barnstable CJ; Bodmer WF; Brown G; Galfre G; Milstein C; Williams AF; Ziegler A
    Cell; 1978 May; 14(1):9-20. PubMed ID: 667938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four examples of anti-TSEN and three of TSEN-positive erythrocytes.
    Storry JR; Lindsay G; Rolih S; Co A; Rodberg K; Harris T; Reid ME
    Vox Sang; 2000; 79(3):175-9. PubMed ID: 11111237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and biochemical characterization of a human surface determinant on somatic cell hybrids: the 4F2 antigen.
    Peters PG; Kamarck ME; Hemler ME; Strominger JL; Ruddle FH
    Somatic Cell Genet; 1982 Nov; 8(6):825-34. PubMed ID: 6187076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three human cell surface antigen systems determined by genes on chromosome 12.
    Dracopoli NC; Rettig WJ; Goetzger TA; Houghton AN; Spengler BA; Oettgen HF; Biedler JL; Old LJ
    Somat Cell Mol Genet; 1984 Sep; 10(5):475-81. PubMed ID: 6206575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emm. A red cell antigen of very high frequency.
    Daniels GL; Taliano V; Klein MT; McCreary J
    Transfusion; 1987; 27(4):319-21. PubMed ID: 3603660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human myeloid-associated surface antigens in human-mouse myeloid cell hybrids.
    Geurts van Kessel AH; Tetteroo PA; von dem Borne AE; Hagemeijer A; Bootsma D
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3748-52. PubMed ID: 6574514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human quantitative polymorphism related to Xg blood groups.
    Goodfellow PN; Tippett P
    Nature; 1981 Jan; 289(5796):404-5. PubMed ID: 7464908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulator genes affecting red cell antigens.
    Tippett P
    Transfus Med Rev; 1990 Jan; 4(1):56-68. PubMed ID: 1983717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting and depletion of circulating leukocytes and cancer cells by lipophilic antibody-modified erythrocytes.
    Mukthavaram R; Shi G; Kesari S; Simberg D
    J Control Release; 2014 Jun; 183():146-53. PubMed ID: 24685706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human alloantibodies detecting a red cell antigen apparently identical to MER2.
    Daniels GL; Levene C; Berrebi A; Schechter Y; Moulds M; Sela R; Poole J; Lacey P; Atkins CJ
    Vox Sang; 1988; 55(3):161-4. PubMed ID: 3238950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A structural/functional domain on human CD36 is involved in the binding of anti-Nak(a) antibodies.
    Daviet L; Morel-Kopp MC; Kaplan C; McGregor JL
    Thromb Haemost; 1995 Mar; 73(3):543-5. PubMed ID: 7545324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.